149 related articles for article (PubMed ID: 16390814)
1. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
Ambruosi A; Yamamoto H; Kreuter J
J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.
Ambruosi A; Khalansky AS; Yamamoto H; Gelperina SE; Begley DJ; Kreuter J
J Drug Target; 2006 Feb; 14(2):97-105. PubMed ID: 16608736
[TBL] [Abstract][Full Text] [Related]
3. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.
Gulyaev AE; Gelperina SE; Skidan IN; Antropov AS; Kivman GY; Kreuter J
Pharm Res; 1999 Oct; 16(10):1564-9. PubMed ID: 10554098
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques.
Reddy LH; Murthy RS
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Dec; 148(2):161-6. PubMed ID: 15744366
[TBL] [Abstract][Full Text] [Related]
6. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
Ambruosi A; Gelperina S; Khalansky A; Tanski S; Theisen A; Kreuter J
J Microencapsul; 2006 Aug; 23(5):582-92. PubMed ID: 16980278
[TBL] [Abstract][Full Text] [Related]
7. Use of nanoparticles for cerebral cancer.
Kreuter J; Gelperina S
Tumori; 2008; 94(2):271-7. PubMed ID: 18564616
[TBL] [Abstract][Full Text] [Related]
8. [Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80].
Basel AA; Petrov VE; Trofimov SS; Voronina TA; Aliautdin RN
Eksp Klin Farmakol; 2005; 68(6):3-8. PubMed ID: 16405025
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
10. Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.
Gelperina SE; Khalansky AS; Skidan IN; Smirnova ZS; Bobruskin AI; Severin SE; Turowski B; Zanella FE; Kreuter J
Toxicol Lett; 2002 Jan; 126(2):131-41. PubMed ID: 11751017
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour.
Reddy LH; Sharma RK; Murthy RS
J Drug Target; 2004; 12(7):443-51. PubMed ID: 15621669
[TBL] [Abstract][Full Text] [Related]
12. Delivery of nanoparticles to the brain detected by fluorescence microscopy.
Reimold I; Domke D; Bender J; Seyfried CA; Radunz HE; Fricker G
Eur J Pharm Biopharm; 2008 Oct; 70(2):627-32. PubMed ID: 18577452
[TBL] [Abstract][Full Text] [Related]
13. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.
Kreuter J; Ramge P; Petrov V; Hamm S; Gelperina SE; Engelhardt B; Alyautdin R; von Briesen H; Begley DJ
Pharm Res; 2003 Mar; 20(3):409-16. PubMed ID: 12669961
[TBL] [Abstract][Full Text] [Related]
15. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad M; Khan ZA
Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
[TBL] [Abstract][Full Text] [Related]
16. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.
Tian XH; Lin XN; Wei F; Feng W; Huang ZC; Wang P; Ren L; Diao Y
Int J Nanomedicine; 2011; 6():445-52. PubMed ID: 21445277
[TBL] [Abstract][Full Text] [Related]
17. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
[TBL] [Abstract][Full Text] [Related]
18. Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain.
Lin Y; Pan Y; Shi Y; Huang X; Jia N; Jiang JY
Nanotechnology; 2012 Apr; 23(16):165101. PubMed ID: 22460562
[TBL] [Abstract][Full Text] [Related]
19. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells.
Ramge P; Unger RE; Oltrogge JB; Zenker D; Begley D; Kreuter J; Von Briesen H
Eur J Neurosci; 2000 Jun; 12(6):1931-40. PubMed ID: 10886334
[TBL] [Abstract][Full Text] [Related]
20. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
